Roxadustat Treatment for Anemia in Patients Undergoing Long-Term Dialysis-Reference-Cited by-同舟云学术

Roxadustat Treatment for Anemia in Patients Undergoing Long-Term Dialysis

Published:2019-09-12 Issue:11 Volume:381 Page:1011-1022
ISSN:0028-4793
Container-title:New England Journal of Medicine
language:en
Short-container-title:N Engl J Med

Author:

Chen Nan¹,Hao Chuanming¹,Liu Bi-Cheng¹,Lin Hongli¹,Wang Caili¹,Xing Changying¹,Liang Xinling¹,Jiang Gengru¹,Liu Zhengrong¹,Li Xuemei¹,Zuo Li¹,Luo Laimin¹,Wang Jianqin¹,Zhao Ming-hui¹,Liu Zhihong¹,Cai Guang-Yan¹,Hao Li¹,Leong Robert¹,Wang Chunrong¹,Liu Cameron¹,Neff Thomas¹,Szczech Lynda¹,Yu Kin-Hung P.¹

Affiliation:

1. From the Department of Nephrology, Institute of Nephrology, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine (N.C.), the Division of Nephrology, Huashan Hospital Fudan University (C.H.), and the Department of Nephrology, Xinhua Hospital Affiliated to Shanghai Jiao Tong University School of Medicine (G.J.), Shanghai, the Institute of Nephrology, Zhong Da Hospital, Southeast University School of Medicine (B.-C.L.), the Department of Nephrology, First Affiliated Hospital (Jiangsu Province...

Funder

FibroGen

Publisher

Massachusetts Medical Society

Subject

General Medicine

Link

http://www.nejm.org/doi/pdf/10.1056/NEJMoa1901713

Cited by 452 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Discovery of DS-1093a: An oral hypoxia-inducible factor prolyl hydroxylase inhibitor for the treatment of renal anemia;Bioorganic & Medicinal Chemistry Letters;2024-10

2. Optimizing the dosing regimen of roxadustat in kidney transplant recipients with early post-transplant anemia;Journal of Pharmaceutical Sciences;2024-09

3. Hypoxia-Inducible Factor Prolyl Hydroxylase Inhibitors as a New Treatment Option for Anemia in Chronic Kidney Disease;Biomedicines;2024-08-18

4. The clinical efficacy of combined ESA and Roxadustat treatment for renal anemia in hemodialysis patients with secondary hyperparathyroidism: A case series;Medicine;2024-08-16

5. Therapeutic approaches and novel antifibrotic agents in renal fibrosis: A comprehensive review;Journal of Biochemical and Molecular Toxicology;2024-08